Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Europe.
Press releases published on August 19, 2025
Earth Science Tech, Inc. Board of Directors Approves Reduction of Authorized Common Stock
GlobeNewswire
·
August 19, 2025
Miami, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Earth Science Tech, Inc. (OTC: ETST) (“ETST” or the “Company”), a strategic holding company focused on acquiring and scaling high-potential businesses, today announced that its Board of Directors has approved …
Madrigal Receives European Commission Approval for Rezdiffra™ (resmetirom) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
GlobeNewswire
·
August 19, 2025
Rezdiffra is the first and only medication approved for people living with MASH in the European Union Conditional marketing authorization is based on positive results from the pivotal Phase 3 MAESTRO-NASH trial demonstrating Rezdiffra reduced fibrosis, …
Celldex Reports Results from Phase 2 Study of Barzolvolimab in Eosinophilic Esophagitis (EoE)
GlobeNewswire
·
August 19, 2025
Study met primary endpoint demonstrating barzolvolimab’s ability to potently deplete mast cells in the gastrointestinal tract Profound mast cell depletion did not result in improved clinical outcomes providing direct evidence that mast cells are not a …
Arcutis to Present at Upcoming Investor Conferences
GlobeNewswire
·
August 19, 2025
WESTLAKE VILLAGE, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a commercial-stage biopharmaceutical company focused on developing meaningful innovations in immuno-dermatology, today announced that Arcutis …
Ligand to Participate in September Investor Conferences
GlobeNewswire
·
August 19, 2025
JUPITER, Fla., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in the following upcoming investor …
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
·
August 19, 2025
SOUTH SAN FRANCISCO, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on August 15, 2025 it granted stock options to purchase an aggregate of 105,169 shares of common stock and 70,879 restricted stock …
NMDP Announces Nationwide Celebration and Fundraiser to Help Patients in Need of Life-Saving Cell Therapy
GlobeNewswire
·
August 19, 2025
MINNEAPOLIS, Aug. 19, 2025 (GLOBE NEWSWIRE) -- NMDP℠ (formerly Be The Match®), a global nonprofit leader in cell therapy, invites communities nationwide to join NMDP Unite: a community celebration to find cures and save lives. This free, family-friendly …
REPEAT -- Tevogen Bio Enters Into Agreement for Up to $50 Million in Financing to Advance R&D and Clinical Development Efforts
GlobeNewswire
·
August 19, 2025
Includes $36 million line of credit and potential $14 million private placement WARREN, N.J., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Tevogen” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech pioneer …
Fayetteville State University Shows Research Muscle in Soy Genetics
GlobeNewswire
·
August 19, 2025
Fayetteville, N.C., Aug. 19, 2025 (GLOBE NEWSWIRE) -- Breeders may soon have a better approach to grow soybeans with more of a health-promoting peptide. In a new peer-reviewed study supported by the National Science Foundation, Fayetteville State …
Epione Beverly Hills Releases Landmark Study Led by Dr. Simon Ourian Confirming Long-Term Effectiveness of Non-Surgical Under-Eye Dark Circle Treatment
GlobeNewswire
·
August 19, 2025
Beverly Hills, CA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Epione Beverly Hills, a leader in non-invasive aesthetic treatments, announced today the results of a landmark four-year retrospective study evaluating its proprietary Coolaser® and Neustem™ technology …
Global Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030
GlobeNewswire
·
August 19, 2025
Boston, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Tissue Engineering and Regeneration: Technologies and Global Markets” is estimated to increase from $5.4 billion in 2025 to $9.8 billion by the end of 2030, at …
Why Healthletic's First-Day Colostrum Is Revolutionizing Whole-Body Wellness: The Science Behind Nature's Original Superfood
GlobeNewswire
·
August 19, 2025
New York, Aug. 19, 2025 (GLOBE NEWSWIRE) -- In an era where wellness enthusiasts chase the latest biohacking trends and superfood supplements, a growing number of health-conscious individuals are turning to one of nature's oldest nutritional powerhouses: …
MedX Holdings, Inc. (OTC: MEDH) Med X Holdings Q2 2025 Investor Update: We’re at an Inflection Point
GlobeNewswire
·
August 19, 2025
Austin, Texas, Aug. 19, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE MedX Holdings, Inc. (OTC: MEDH) Med-X Holdings Q2 2025 Investor Update: We’re at an Inflection Point Sales up; on track for ~$1.5M FY25 revenue. Las Vegas lounge approaching approvals. …
Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Analysis Demonstrates 12+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight
GlobeNewswire
·
August 19, 2025
New York, USA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Analysis Demonstrates 12+ Key Companies at the Horizon Expected to Transform the Treatment Paradigm, Assesses DelveInsight Focal Segmental …
Global Digital Twins in Healthcare Market to Exhibit Tremendous Growth at a CAGR of ~28% by 2032 | DelveInsight
GlobeNewswire
·
August 19, 2025
New York, USA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Global Digital Twins in Healthcare Market to Exhibit Tremendous Growth at a CAGR of ~28% by 2032 | DelveInsight The growing use of digital twins in healthcare is largely fueled by the increasing prevalence …
Tevogen Delivers Stronger Second Quarter and First Half 2025 Financial Results with Reduced Expenses and Growth Momentum
GlobeNewswire
·
August 19, 2025
Expenses significantly lower with expansion on multiple efforts; Q2 2025 loss from operations reduced to $5.4 million vs $8.6 million in Q2 2024. Tevogen maximizes capital efficiency, maintains access to financing to support growth, and anticipates revenue …
TRYVIO™ (aprocitentan) now included in ACC/AHA Clinical Practice Guidelines for the treatment of hypertension
GlobeNewswire
·
August 19, 2025
The updated recommendations now include TRYVIO™ (aprocitentan) – the first and only hypertension treatment targeting the endothelin pathway. Endothelin is upregulated in hypertension and is a fundamental mediator in patients whose hypertension is difficult …
Life Backup Plan to Be Featured on Business Today with Bill and Giuliana Rancic
GlobeNewswire
·
August 19, 2025
Aliso Viejo, CA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Life Backup Plan, the Interoperable Lifecare Platform redefining digital health and safety, is set to be featured on Business Today, hosted by Bill and Giuliana Rancic. CEO and Founder Sandy Eulitt will …
24/7 Market News: LIXTE Biotechnology Spotlight- Revisiting the “Too Much of a Good Thing” Strategy for LB-100
GlobeNewswire
·
August 19, 2025
DENVER, Aug. 19, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and corporate information, revisits the LIXTE Biotechnology Holdings, Inc. (Nasdaq: LIXT), a clinical-stage …
First Lady Anna Stein, NCDHHS, Morse Clinics Celebrate First Mobile OTP Unit in North Carolina
GlobeNewswire
·
August 19, 2025
Raleigh, NC, Aug. 19, 2025 (GLOBE NEWSWIRE) -- North Carolina on Tuesday took an innovative step in efforts to reduce opioid use and related deaths with the launch of the state’s first Mobile Opioid Treatment Program. First Lady Anna Stein helped …